Showing results (831-840 of 927) with videos related to

Sort By:
Pageof 93
Thrombosis and Haemostasis|December 18, 2015
Supportive management strategies for disseminated intravascular coagulation. An international consensusAlessandro Squizzato, Beverley J Hunt, Gary T Kinasewitz, et al.
JAMA|February 24, 2016
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Mervyn Singer, Clifford S Deutschman, Christopher Warren Seymour, et al.
Plos Medicine|December 10, 2015
A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent CohortsLeo McHugh, Therese A Seldon, Roslyn A Brandon, et al.
BMJ Open|January 5, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocolAntigone Kotsaki, Peter Pickkers, Michael Bauer, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Journal of Critical Care|June 6, 2007
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safetyPierre-Francois Laterre, David R Nelson, William Macias, et al.
Plos Pathogens|May 23, 2009
The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferiJoppe W R Hovius, Maarten F Bijlsma, Gerritje J W van der Windt, et al.
Transfusion|May 26, 2007
Recombinant human C1-inhibitor in the treatment of acute angioedema attacksGoda Choi, Maarten R Soeters, Henriette Farkas, et al.
Intensive Care Medicine Experimental|August 18, 2025
A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patientsNiels van Mourik, Rombout B E van Amstel, Marleen A Slim, et al.
Thrombosis and Haemostasis|June 4, 2004
Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteersMichael Wolzt, Marcel Levi, Troy C Sarich, et al.
Pageof 93